Glucagon-Like Peptide-1 Receptor Agonists And Cardiovascular Risk Reduction In Type 2 Diabetes Mellitus: Is It A Class Effect?

Yixing Li, Paul D. Rosenblit

Save to my Library

Download PDF

Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager

Time to take this seriously.